Patents by Inventor Steinunn Thorlacius

Steinunn Thorlacius has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENETIC VARIANTS ON CHR 11Q AND 6Q AS MARKERS FOR PROSTATE AND COLORECTAL CANCER PREDISPOSITION
    Publication number: 20140248615
    Abstract: It has been discovered that certain polymorphic markers on chromosome 6 and chromosome 11 are indicative of a susceptibility to prostate cancer and colon cancer. The invention describes diagnostic applications for determining a susceptibility to cancer using such markers, as well as kits for use in such applications.
    Type: Application
    Filed: March 6, 2014
    Publication date: September 4, 2014
    Applicant: deCODE Genetics ehf.
    Inventors: Steinunn Thorlacius, Patrick Sulem, Julius Gudmundsson
  • Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
    Patent number: 8697360
    Abstract: It has been discovered that certain polymorphic markers on chromosome 6 and chromosome 11 are indicative of a susceptibility to prostate cancer and colon cancer. The invention describes diagnostic applications for determining a susceptibility to cancer using such markers, as well as kits for use in such applications.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: April 15, 2014
    Assignee: deCODE Genetics ehf.
    Inventors: Steinunn Thorlacius, Patrick Sulem, Julius Gudmundsson
  • Genetic Variants as Markers for Use in Urinary Bladder Cancer Risk Assessment, Diagnosis, Prognosis and Treatment
    Publication number: 20110269143
    Abstract: It has been discovered that certain genetic variants correlate with risk of urinary bladder cancer in humans. The invention relates to use of such variants in methods of disease management of urinary bladder cancer, including various diagnostic methods.
    Type: Application
    Filed: July 3, 2009
    Publication date: November 3, 2011
    Applicant: deCODE Genetics ehf.
    Inventors: Steinunn Thorlacius, Patrick Sulem
  • Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
    Publication number: 20110053281
    Abstract: It has been discovered that certain polymorphic markers on chromosome 6 and chromosome 11 are indicative of a susceptibility to prostate cancer and colon cancer. The invention describes diagnostic applications for determining a susceptibility to cancer using such markers, as well as kits for use in such applications.
    Type: Application
    Filed: November 26, 2008
    Publication date: March 3, 2011
    Inventors: Steinunn Thorlacius, Patrick Sulem, Julius Gudmundsson